$4.11
-0.02[-0.48%]
Last update: 8:50AM Get Real Time Here
Exscientia
(NASDAQ:EXAI)Exscientia Stock (NASDAQ:EXAI), Analyst Ratings, Price Targets, Predictions
Exscientia PLC has a consensus price target of $11.8, established from looking at the 23 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, B of A Securities, and Barclays on April 22, 2024, January 5, 2024, and October 17, 2023. With an average price target of $8.67 between Morgan Stanley, B of A Securities, and Barclays, there's an implied 117.76% upside for Exscientia PLC from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
B of A Securities
Barclays
Berenberg
Goldman Sachs
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Exscientia
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/22/2024 | EXAI | Buy Now | Exscientia | $3.98 | 75.88% | Morgan Stanley | Vikram Purohit | $7 → $7 | Maintains | Equal-Weight | Get Alert |
| 01/05/2024 | EXAI | Buy Now | Exscientia | $3.98 | 126.14% | B of A Securities | Michael Ryskin | $11 → $9 | Downgrade | Buy → Neutral | Get Alert |
| 10/17/2023 | EXAI | Buy Now | Exscientia | $3.98 | 151.26% | Barclays | Peter Lawson | $12 → $10 | Maintains | Overweight | Get Alert |
| 10/11/2023 | EXAI | Buy Now | Exscientia | $3.98 | 75.88% | Morgan Stanley | Vikram Purohit | $14 → $7 | Maintains | Equal-Weight | Get Alert |
| 08/01/2023 | EXAI | Buy Now | Exscientia | $3.98 | 251.77% | Morgan Stanley | Vikram Purohit | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/31/2023 | EXAI | Buy Now | Exscientia | $3.98 | 251.77% | Morgan Stanley | Vikram Purohit | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/24/2023 | EXAI | Buy Now | Exscientia | $3.98 | 251.77% | Morgan Stanley | Vikram Purohit | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/21/2023 | EXAI | Buy Now | Exscientia | $3.98 | 226.64% | Berenberg | Gaurav Goparaju | → $13 | Initiates | → Buy | Get Alert |
| 07/20/2023 | EXAI | Buy Now | Exscientia | $3.98 | 251.77% | Morgan Stanley | Vikram Purohit | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/17/2023 | EXAI | Buy Now | Exscientia | $3.98 | 251.77% | Morgan Stanley | Vikram Purohit | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/26/2023 | EXAI | Buy Now | Exscientia | $3.98 | 251.77% | Morgan Stanley | Vikram Purohit | $14 → $14 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 06/20/2023 | EXAI | Buy Now | Exscientia | $3.98 | 251.77% | Morgan Stanley | Vikram Purohit | → $14 | Reiterates | → Equal-Weight | Get Alert |
| 06/12/2023 | EXAI | Buy Now | Exscientia | $3.98 | 251.77% | Morgan Stanley | Vikram Purohit | → $14 | Reiterates | → Equal-Weight | Get Alert |
| 04/10/2023 | EXAI | Buy Now | Exscientia | $3.98 | 251.77% | Morgan Stanley | Vikram Purohit | $15 → $14 | Maintains | Equal-Weight | Get Alert |
| 11/16/2022 | EXAI | Buy Now | Exscientia | $3.98 | 201.52% | Barclays | Peter Lawson | $40 → $12 | Maintains | Overweight | Get Alert |
| 09/09/2022 | EXAI | Buy Now | Exscientia | $3.98 | 276.89% | Morgan Stanley | Vikram Purohit | $18 → $15 | Maintains | Equal-Weight | Get Alert |
| 08/24/2022 | EXAI | Buy Now | Exscientia | $3.98 | 352.27% | Morgan Stanley | Vikram Purohit | $20 → $18 | Maintains | Equal-Weight | Get Alert |
| 06/13/2022 | EXAI | Buy Now | Exscientia | $3.98 | 402.53% | Morgan Stanley | Vikram Purohit | $21 → $20 | Maintains | Equal-Weight | Get Alert |
| 05/24/2022 | EXAI | Buy Now | Exscientia | $3.98 | 402.53% | Goldman Sachs | Chris Shibutani | $23 → $20 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Exscientia (EXAI)?
The latest price target for Exscientia (NASDAQ: EXAI) was reported by Morgan Stanley on April 22, 2024. The analyst firm set a price target for $7.00 expecting EXAI to rise to within 12 months (a possible 70.32% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Exscientia (EXAI)?
The latest analyst rating for Exscientia (NASDAQ: EXAI) was provided by Morgan Stanley, and Exscientia maintained their equal-weight rating.
When was the last upgrade for Exscientia (EXAI)?
There is no last upgrade for Exscientia.
When was the last downgrade for Exscientia (EXAI)?
The last downgrade for Exscientia PLC happened on January 5, 2024 when B of A Securities changed their price target from $11 to $9 for Exscientia PLC.
When is the next analyst rating going to be posted or updated for Exscientia (EXAI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exscientia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exscientia was filed on April 22, 2024 so you should expect the next rating to be made available sometime around April 22, 2025.
Is the Analyst Rating Exscientia (EXAI) correct?
While ratings are subjective and will change, the latest Exscientia (EXAI) rating was a maintained with a price target of $7.00 to $7.00. The current price Exscientia (EXAI) is trading at is $4.11, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.